Constellation Healthcare Tech, Inc Further re Acquisition (2407L)
September 29 2016 - 10:11AM
UK Regulatory
TIDMCHT
RNS Number : 2407L
Constellation Healthcare Tech, Inc
29 September 2016
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS
RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN
WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE
UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER
JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION
WOULD BE UNLAWFUL. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION
FOR THE PURPOSES OF Article 7 of EU Regulation 596/2014.
29 September 2016
Constellation Healthcare Technologies, Inc.
("Constellation Healthcare Technologies", "CHT", "Company" or
the "Group")
Further re Acquisition of VEGA Medical Professionals LLC
Further to the announcement released on 23 September 2016,
Constellation Healthcare Technologies, Inc., the US based
Healthcare Services Company, announces that the shares potentially
due to the vendors of Vega Medical Professionals LLC ("Vega") under
the terms of the three year earn out have been allotted and will be
held in an escrow account until such time as certain revenue and
EBITDA targets have been met by VEGA. The maximum number of shares
that could be issued under the terms of the earn out is 989,011
based on an issue price of GBP1.40 ("Deferred Consideration
Shares").
Application has been made for the Deferred Consideration Shares
to be admitted to trading on AIM and admission is expected to occur
on 30 September 2016 ("Admission"). Following Admission, the total
number of issued common shares in the Company will be 91,357,782.
This figure has not changed from the announcement dated 23
September 2016 as the Deferred Consideration Shares were included
in the calculation of this figure at that time. The Company does
not hold any common shares in treasury and therefore this figure
may be used by shareholders as the denominator for the calculations
by which they will determine if they are required to notify their
interest in, or a change to their interest in, the share capital of
the Company.
Enquiries:
Constellation Healthcare c/o Redleaf Communications
Technologies +44 (0)20 7382
Paul Parmar, Chief Executive 4730
Officer
Sotirios 'Sam' Zaharis, Chief
Financial Officer
finnCap - Nominated Adviser
and Joint Broker
Julian Blunt / Scott Mathieson
- corporate finance
Simon Johnson - corporate +44 (0)20 7220
broking 0568
Stifel Nicholas Europe Limited
- Joint Broker +44 (0)20 7710
Jonathan Senior / Ben Maddison 7600
Redleaf Communications - +44 (0)20 7382
PR adviser 4730
Charlie Geller / Sam Modlin constellation@redleafpr.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
ACQAKCDDQBKDKCB
(END) Dow Jones Newswires
September 29, 2016 10:11 ET (14:11 GMT)
Constellation Healthcare (LSE:CHT)
Historical Stock Chart
From Apr 2024 to May 2024
Constellation Healthcare (LSE:CHT)
Historical Stock Chart
From May 2023 to May 2024